权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Village-Integrated Eye Worker trial II (VIEW II)

村庄综合眼科工作者试验 II (VIEW II)

基本信息

批准号：
9788451
负责人：
Jeremy David Keenan
金额：
$ 44.49万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-30 至 2023-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9788451
关键词：
Address Adult Affect Age Age related macular degeneration Blindness Caring Cataract Cataract Extraction Censuses Clinic Cluster randomized trial Communities Community Health Aides Counseling Detection Developing Countries Diabetic Retinopathy Diagnosis Diagnostic Disease Early Diagnosis Economics Effectiveness Equation Event Eye Eye diseases Fees Glaucoma Goals Health Health Care Costs Hospitals Human Resources Improve Access Individual Intervention Mass Screening Methods Modeling Monitor National Eye Institute Nepal Operative Surgical Procedures Patients Population Prevention Prevention program Public Health Quality of life Randomized Randomized Controlled Trials Refractive Errors Research Resources Risk Running System Technology Telemedicine Testing Time Travel Vision Visual Acuity Visual impairment World Health Organization aged arm base care systems community intervention comparative effectiveness cost cost effective cost effectiveness cost-effectiveness ratio early screening effective therapy follow-up improved incremental cost-effectiveness innovation local economy meetings mobile computing outreach outreach program population based portability post intervention prevent programs screening screening program skills tool treatment arm trial design volunteer

项目摘要

PROJECT SUMMARY/ABSTRACT The World Health Organization estimates that 80% of blindness worldwide is avoidable, yet cases are not detected early enough to prevent vision loss. To address this global burden, eye care systems must determine optimal methods for identifying people with or at risk for visual impairment. Worldwide, systems utilize a variety of community-based approaches to identify such cases, including screening for early disease with telemedicine and case detection of prevalent disease with cataract camps or community health workers. Each of these models requires varying levels of resources and ophthalmic skill, but no studies have been conducted on the comparative effectiveness or cost effectiveness of these different approaches. The overall objective of this project is to determine the effectiveness of community-based approaches to prevent blindness through a cluster-randomized trial. Communities in Nepal will be randomized to one of five arms (1) a state-of-the-art mobile screening unit employing telemedicine for screening and case detection, (2) a mobile case detection unit focused on cataract and refractive error only, (3) a cataract camp employing ophthalmic personnel, (4) a volunteer community health worker (CHW) program, and (5) no intervention. Intervention arms (arms 1-4) will target all adults aged ≥50 years residing in intervention communities for screening and/or case detection. Those meeting referral criteria will be referred to Bharatpur Eye Hospital for a confirmatory diagnosis and follow-up care as needed, and will be closely monitored by study staff. Four years after implementation, a population-based census will be conducted in all study communities, and eligible adults will undergo a visual acuity assessment. To examine effectiveness and cost-effectiveness of these approaches, we will pursue three specific aims: 1) to determine whether screening is effective for reducing visual impairment relative to case detection (arm 1 vs 2); 2) to determine whether a CHW program increases the rate of cataract surgery compared to cataract camp (arm 3 vs 4); and 3) to compare the costs per line of visual impairment prevented between competing outreach programs (arms 1-5). The approach is innovative in its use of recently developed portable diagnostic technology that enables mobile, telemedicine-based screening on this large scale. In addition, the post-test only population-based assessment of visual acuity in a large trial design allows for the study of a rare event like blindness and eliminates the problem of loss to follow- up that affected previous screening trials. This research is significant because it will provide the strongest type of evidence to guide national eye health programs – results from a randomized controlled trial. Ultimately, this trial will benefit blindness prevention programs worldwide in deciding how to allocate limited resources to screening or case detection.

项目总结/文摘